Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS

3.4.1. MARKET DYNAMICS
3.4.2. Drivers
3.4.3. Restraints
3.4.4. Opportunities

Chapter: 4 GLOBAL FLONICAMID MARKET, BY FORM

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. POWDER

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. SOLUTION

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

Chapter: 5 GLOBAL FLONICAMID MARKET, BY APPLICATION

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. FRUITS

5.2.1. Market size and forecast

5.3. VEGETABLES

5.3.1. Market size and forecast

5.4. OTHERS

5.4.1. Market size and forecast

Chapter: 6 GLOBAL FLONICAMID MARKET, BY GEOGRAPHY

6.1. OVERVIEW
6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast

6.2.3.1. By Form
6.2.3.2. By Application

6.2.4. U.S.

6.2.4.1. Market size and forecast, by Form
6.2.4.2. Market size and forecast, by Application

6.2.5. Canada

6.2.5.1. Market size and forecast, by Form
6.2.5.2. Market size and forecast, by Application

6.2.6. Mexico

6.2.6.1. Market size and forecast, by Form
6.2.6.2. Market size and forecast, by Application

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast

6.3.3.1. By Form
6.3.3.2. By Application

6.3.4. Germany

6.3.4.1. Market size and forecast, by Form
6.3.4.2. Market size and forecast, by Application

6.3.5. France

6.3.5.1. Market size and forecast, by Form
6.3.5.2. Market size and forecast, by Application

6.3.6. UK

6.3.6.1. Market size and forecast, by Form
6.3.6.2. Market size and forecast, by Application

6.3.7. Italy

6.3.7.1. Market size and forecast, by Form
6.3.7.2. Market size and forecast, by Application

6.3.8. Rest of Europe

6.3.8.1. Market size and forecast, by Form
6.3.8.2. Market size and forecast, by Application

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast

6.4.3.1. By Form
6.4.3.2. By Application

6.4.4. China

6.4.4.1. Market size and forecast, by Form
6.4.4.2. Market size and forecast, by Application

6.4.5. Japan

6.4.5.1. Market size and forecast, by Form
6.4.5.2. Market size and forecast, by Application

6.4.6. India

6.4.6.1. Market size and forecast, by Form
6.4.6.2. Market size and forecast, by Application

6.4.7. Australia

6.4.7.1. Market size and forecast, by Form
6.4.7.2. Market size and forecast, by Application

6.4.8. Korea

6.4.8.1. Market size and forecast, by Form
6.4.8.2. Market size and forecast, by Application

6.4.9. Rest of Asia-Pacific

6.4.9.1. Market size and forecast, by Form
6.4.9.2. Market size and forecast, by Application

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast

6.5.3.1. By Form
6.5.3.2. By Application

6.5.4. Brazil

6.5.4.1. Market size and forecast, by Form
6.5.4.2. Market size and forecast, by Application

6.5.5. Saudi Arabia

6.5.5.1. Market size and forecast, by Form
6.5.5.2. Market size and forecast, by Application

6.5.6. South Africa

6.5.6.1. Market size and forecast, by Form
6.5.6.2. Market size and forecast, by Application

6.5.7. Rest of LAMEA

6.5.7.1. Market size and forecast, by Form
6.5.7.2. Market size and forecast, by Application

Chapter: 7 COMPANY PROFILES

7.1. ISK BIOSCIENCES CORPORATION

7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments

7.2. TOPSEN BIOTECH CO., LTD

7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments

7.3. STAR BIO SCIENCE

7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments

7.4. NANJING KAIHENG CHEMICAL CO., LTD

7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments

7.5. AHH CHEMICAL

7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments

7.6. SIGMA-ALDRICH CO. LLC

7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments

7.7. FINETECH INDUSTRY LIMITED

7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments

7.8. SHANGHAI CHEMICAL CHEMICAL TECHNOLOGY CO., LTD.,

7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments

7.9. BASF SE,

7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments

7.10. IS CHEMICAL TECHNOLOGY LTD.

7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments